PEP

HIV Post-Exposure Prophylaxis (PEP) Guidelines

By

Therapeutic Guidelines Menu About COVID-19 Primary Care Guidelines Adults Pediatric Management of Acute HIV Infections HIV Post-Exposure Prophylaxis (PEP) Guidelines Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia For information on how to obtain medication for prevention of HIV infection following a high risk occupational or

HIV Post-Exposure Prophylaxis (PEP) Guidelines Read More »

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025

Start typing and press enter to search